These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23053881)

  • 1. Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes.
    Mancera-Romero J; Sánchez-Chaparro MA; Rioja J; Ariza MJ; Olivecrona G; González-Santos P; Valdivielso P
    Acta Diabetol; 2013 Jun; 50(3):383-9. PubMed ID: 23053881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls.
    Valdivielso P; Puerta S; Rioja J; Alonso I; Ariza MJ; Sánchez-Chaparro MA; Palacios R; González-Santos P
    Clin Chim Acta; 2010 Mar; 411(5-6):433-7. PubMed ID: 20059992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents.
    Hanyu O; Miida T; Kosuge K; Ito T; Soda S; Hirayama S; Wardaningsih E; Fueki Y; Obayashi K; Aizawa Y
    Clin Chim Acta; 2007 Sep; 384(1-2):118-23. PubMed ID: 17651713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apo E genotype, diabetes, and peripheral arterial disease in older men: the Honolulu Asia-aging study.
    Resnick HE; Rodriguez B; Havlik R; Ferrucci L; Foley D; Curb JD; Harris TB
    Genet Epidemiol; 2000 Jul; 19(1):52-63. PubMed ID: 10861896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting apolipoprotein B48 is associated with asymptomatic peripheral arterial disease in type 2 diabetic subjects: a case-control study.
    Lapice E; Cipriano P; Patti L; Romano G; Vaccaro O; Rivellese AA
    Atherosclerosis; 2012 Aug; 223(2):504-6. PubMed ID: 22762727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
    Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
    J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy.
    Miyashita Y; Shirai K; Itoh Y; Sasaki H; Totsuka M; Murano T; Watanabe H
    Diabetes Res Clin Pract; 2002 Jun; 56(3):181-7. PubMed ID: 11947965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes.
    Fukui M; Tanaka M; Senmaru T; Nakanishi M; Mukai J; Ohki M; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Metabolism; 2013 Jul; 62(7):935-8. PubMed ID: 23433938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of the relationship between ankle-brachial index and estimated glomerular filtration rate in type 2 diabetes.
    Jin X; Ma JH; Shen Y; Luo Y; Su XF; Chen YY; Qi SK; Wu JD
    Angiology; 2013 Apr; 64(3):237-41. PubMed ID: 23162006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice.
    Alipour A; Valdivielso P; Elte JW; Janssen HW; Rioja J; van der Meulen N; van Mechelen R; Njo TL; González-Santos P; Rietveld AP; Cabezas MC
    Eur J Clin Invest; 2012 Jul; 42(7):702-8. PubMed ID: 22224712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variance of mean platelet volume in subjects with normal glucose tolerance, impaired glucose regulation and type 2 diabetic mellitus and its relationship with diabetic peripheral artery disease].
    Li S; Wang C; Zhong XW; Li HQ; Fu XQ; Ran XW
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):232-5. PubMed ID: 22490792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toe-brachial index is associated more strongly with albuminuria or glomerular filtration rate than ankle-brachial index in patients with type 2 diabetes.
    Fukui M; Tanaka M; Hamaguchi M; Senmaru T; Sakabe K; Asano M; Yamazaki M; Hasegawa G; Imai S; Nakamura N
    Hypertens Res; 2012 Jul; 35(7):745-9. PubMed ID: 22336768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease.
    Aboyans V; Lacroix P; Tran MH; Salamagne C; Galinat S; Archambeaud F; Criqui MH; Laskar M
    J Vasc Surg; 2011 Apr; 53(4):984-91. PubMed ID: 21215587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report.
    Valdivielso P; Rioja J; García-Arias C; Sánchez-Chaparro MA; González-Santos P
    Cardiovasc Diabetol; 2009 Jan; 8():1. PubMed ID: 19133114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and factors associated with peripheral artery disease in patients with type 2 diabetes mellitus in Primary Care].
    Montero-Monterroso JL; Gascón-Jiménez JA; Vargas-Rubio MD; Quero-Salado C; Villalba-Marín P; Pérula-de Torres LA
    Semergen; 2015; 41(4):183-90. PubMed ID: 25042974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.
    Saiki A; Oyama T; Endo K; Ebisuno M; Ohira M; Koide N; Murano T; Miyashita Y; Shirai K
    Diabetes Res Clin Pract; 2007 Apr; 76(1):93-101. PubMed ID: 16956692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.